|
Description:
|
|
Featuring articles on relugolix for androgen-deprivation therapy, enzalutamide in prostate cancer, rituximab and chemotherapy in pediatric high-grade lymphoma, handgun ownership and suicide in California, and dynamic developments in screening candidate drugs; review articles on bedbugs and on the cardiovascular consequences of acute kidney injury; a Clinical Problem-Solving on the game is afoot; and Perspective articles on lower prices and greater patient access, on specialty drugs, on ensuring and sustaining a pandemic workforce, and on waiting. |